Empagliflozin Treatment in Kidney Transplant Recipients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Empagliflozin Treatment in Kidney Transplant Recipients	Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, kidney disorder, kidney failure, metabolic disease, proteinuria, urinary system disorder	Recruiting	Phase 4	2026-04-21		NCT06013865

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Iowa City VA Health Care System	1
VA Hines Health Care	2
VA Office of Research and Development	472
VA Pittsburgh Healthcare System	12
VA Tennessee Valley Health Care System	4

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Edward Hines Jr. VA Hospital, Hines, IL	Hines	United States	23
Iowa City VA Health Care System, Iowa City, IA	Iowa City	United States	6
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE	Omaha	United States	14
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN	Nashville	United States	15
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA	Pittsburgh	United States	23